Esophagus to Small Intestine
Increased mortality in achalasia
01/2026
Endoscopic versus surgical gastroenterostomy for palliation of malignant outlet obstruction
01/2026
Subcutaneous induction therapy with guselkumab in Crohn's disease (GRAVITI)
11/2025
Monitoring of Barrett's esophagus using a capsule sponge test
11/2025
New standard neoadjuvant chemotherapy for gastric and gastroesophageal junction cancer
10/2025
Therapy with the IL-23 antibody guselkumab for Crohn’s disease
10/2025
Capsule endoscopy-guided proactive treat-to-target therapy for patients with quiescent small intestinal Crohn’s disease
08/2025
Etrasimod as a treatment for eosinophilic oesophagitis
08/2025
Risankizumab in multirefractory Crohn's disease
02/2025
Semaglutide versus tirzepatide for weight loss
02/2025
Clinical outcomes of potential coeliac disease (PCD)
01/2025
GLP-1 receptor agonists before upper gastrointestinal (GI) endoscopy are not associated with increased risk of aspiration
12/2024
Gastric cancer prevention by community eradication of Helicobacter pylori
10/2024
(EEN) is associated with better long-term outcomes than corticosteroid therapy in children with Morbus Crohn
10/2024
Ustekinumab Vs. risankizumab for
Crohn’s disease
9/2024
New entity of adult ultra-short celiac disease
9/2024
Understanding the malignant potential of gastric metaplasia of the oesophagus and its relevance to Barrett's oesophagus surveillance
6/2024
Clinical predictors of early and late endoscopic recurrence following ileocolonic resection in Crohn's disease
6/2024
Standard of care versus octreotide in angiodysplasia-related bleeding (the OCEAN study): A multicenter randomized controlled trial.
5/2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): An open-label, multicentre, randomised controlled trial.
5/2024